HEADER TRANSFERASE/TRANSFERASE INHIBITOR 26-SEP-13 4MXY TITLE SRC M314L T338M DOUBLE MUTANT BOUND TO KINASE INHIBITOR BOSUTINIB COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN, UNP RESIDUES 254-536; COMPND 5 SYNONYM: PROTO-ONCOGENE C-SRC, PP60C-SRC, P60-SRC; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SRC, SRC1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS KINASE, PHOSPHORYLATION, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR N.M.LEVINSON,S.G.BOXER REVDAT 3 28-FEB-24 4MXY 1 REMARK SEQADV REVDAT 2 05-FEB-14 4MXY 1 JRNL REVDAT 1 25-DEC-13 4MXY 0 JRNL AUTH N.M.LEVINSON,S.G.BOXER JRNL TITL A CONSERVED WATER-MEDIATED HYDROGEN BOND NETWORK DEFINES JRNL TITL 2 BOSUTINIB'S KINASE SELECTIVITY. JRNL REF NAT.CHEM.BIOL. V. 10 127 2014 JRNL REFN ISSN 1552-4450 JRNL PMID 24292070 JRNL DOI 10.1038/NCHEMBIO.1404 REMARK 2 REMARK 2 RESOLUTION. 2.58 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.7_650) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.58 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 61.89 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.970 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.1 REMARK 3 NUMBER OF REFLECTIONS : 21929 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.211 REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.266 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.050 REMARK 3 FREE R VALUE TEST SET COUNT : 1107 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 61.8940 - 5.1640 0.96 2635 152 0.2264 0.2596 REMARK 3 2 5.1640 - 4.0991 0.97 2679 152 0.1753 0.2236 REMARK 3 3 4.0991 - 3.5810 0.96 2670 129 0.1944 0.2707 REMARK 3 4 3.5810 - 3.2536 0.96 2646 138 0.2066 0.2675 REMARK 3 5 3.2536 - 3.0204 0.96 2633 150 0.2193 0.2959 REMARK 3 6 3.0204 - 2.8423 0.96 2670 117 0.2252 0.2719 REMARK 3 7 2.8423 - 2.7000 0.96 2653 147 0.2282 0.3280 REMARK 3 8 2.7000 - 2.5820 0.81 2236 122 0.2424 0.2823 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.39 REMARK 3 B_SOL : 30.99 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.350 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.180 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.40680 REMARK 3 B22 (A**2) : -7.85520 REMARK 3 B33 (A**2) : 10.26210 REMARK 3 B12 (A**2) : -0.98420 REMARK 3 B13 (A**2) : -0.22230 REMARK 3 B23 (A**2) : 5.03640 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 4454 REMARK 3 ANGLE : 1.131 6037 REMARK 3 CHIRALITY : 0.074 640 REMARK 3 PLANARITY : 0.008 765 REMARK 3 DIHEDRAL : 19.446 1695 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4MXY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-OCT-13. REMARK 100 THE DEPOSITION ID IS D_1000082505. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-MAR-13 REMARK 200 TEMPERATURE (KELVIN) : 77 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 2 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.007 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21938 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.582 REMARK 200 RESOLUTION RANGE LOW (A) : 72.700 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.8 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : 0.19500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.58 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.74 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.2 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : 0.47500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.97 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.93 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0-4% PEG 3350, 0.2M AMMONIUM ACETATE, REMARK 280 0.1M HEPES PH 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 248 REMARK 465 HIS A 249 REMARK 465 MET A 250 REMARK 465 GLN A 251 REMARK 465 THR A 252 REMARK 465 GLN A 253 REMARK 465 GLY A 254 REMARK 465 LEU A 255 REMARK 465 ALA A 256 REMARK 465 ASP A 413 REMARK 465 ASN A 414 REMARK 465 GLU A 415 REMARK 465 TYR A 416 REMARK 465 THR A 417 REMARK 465 ALA A 418 REMARK 465 ARG A 419 REMARK 465 GLN A 420 REMARK 465 GLY A 421 REMARK 465 ALA A 422 REMARK 465 LYS A 423 REMARK 465 GLY B 248 REMARK 465 HIS B 249 REMARK 465 MET B 250 REMARK 465 GLN B 251 REMARK 465 THR B 252 REMARK 465 GLN B 253 REMARK 465 GLY B 254 REMARK 465 LEU B 255 REMARK 465 ALA B 256 REMARK 465 LYS B 257 REMARK 465 GLU B 412 REMARK 465 ASP B 413 REMARK 465 ASN B 414 REMARK 465 GLU B 415 REMARK 465 TYR B 416 REMARK 465 THR B 417 REMARK 465 ALA B 418 REMARK 465 ARG B 419 REMARK 465 GLN B 420 REMARK 465 GLY B 421 REMARK 465 ALA B 422 REMARK 465 LYS B 423 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 708 O HOH B 722 1.95 REMARK 500 O ARG A 460 O HOH A 706 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 270 -100.20 -107.16 REMARK 500 PRO A 299 -92.31 -4.33 REMARK 500 THR A 301 -48.26 -18.88 REMARK 500 PRO A 304 -83.36 -49.84 REMARK 500 LEU A 308 57.90 -105.23 REMARK 500 GLN A 309 -11.57 -140.18 REMARK 500 ARG A 318 78.78 -167.75 REMARK 500 SER A 330 -2.69 -142.93 REMARK 500 GLU A 331 73.31 -65.12 REMARK 500 ARG A 385 -16.55 78.79 REMARK 500 PHE A 405 28.65 -70.40 REMARK 500 PRO A 425 106.54 -52.37 REMARK 500 GLU B 270 -76.00 -104.56 REMARK 500 PHE B 278 14.95 -140.55 REMARK 500 THR B 289 -44.95 -130.32 REMARK 500 HIS B 319 141.22 -174.42 REMARK 500 ASN B 381 35.19 72.64 REMARK 500 ARG B 385 -36.87 89.14 REMARK 500 ASP B 404 75.68 52.13 REMARK 500 GLU B 486 7.17 57.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 LYS A 298 PRO A 299 -146.24 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DB8 A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DB8 B 601 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4MXO RELATED DB: PDB REMARK 900 HUMAN SRC KINASE BOUND TO KINASE INHIBITOR BOSUTINIB REMARK 900 RELATED ID: 4MXX RELATED DB: PDB REMARK 900 HUMAN SRC A403T MUTANT BOUND TO KINASE INHIBITOR BOSUTINIB REMARK 900 RELATED ID: 4MXZ RELATED DB: PDB REMARK 900 SRC M314L T338M DOUBLE MUTANT BOUND TO KINASE INHIBITOR BOSUTINIB DBREF 4MXY A 251 533 UNP P12931 SRC_HUMAN 254 536 DBREF 4MXY B 251 533 UNP P12931 SRC_HUMAN 254 536 SEQADV 4MXY GLY A 248 UNP P12931 EXPRESSION TAG SEQADV 4MXY HIS A 249 UNP P12931 EXPRESSION TAG SEQADV 4MXY MET A 250 UNP P12931 EXPRESSION TAG SEQADV 4MXY LEU A 314 UNP P12931 MET 317 ENGINEERED MUTATION SEQADV 4MXY MET A 338 UNP P12931 THR 341 ENGINEERED MUTATION SEQADV 4MXY GLY B 248 UNP P12931 EXPRESSION TAG SEQADV 4MXY HIS B 249 UNP P12931 EXPRESSION TAG SEQADV 4MXY MET B 250 UNP P12931 EXPRESSION TAG SEQADV 4MXY LEU B 314 UNP P12931 MET 317 ENGINEERED MUTATION SEQADV 4MXY MET B 338 UNP P12931 THR 341 ENGINEERED MUTATION SEQRES 1 A 286 GLY HIS MET GLN THR GLN GLY LEU ALA LYS ASP ALA TRP SEQRES 2 A 286 GLU ILE PRO ARG GLU SER LEU ARG LEU GLU VAL LYS LEU SEQRES 3 A 286 GLY GLN GLY CYS PHE GLY GLU VAL TRP MET GLY THR TRP SEQRES 4 A 286 ASN GLY THR THR ARG VAL ALA ILE LYS THR LEU LYS PRO SEQRES 5 A 286 GLY THR MET SER PRO GLU ALA PHE LEU GLN GLU ALA GLN SEQRES 6 A 286 VAL LEU LYS LYS LEU ARG HIS GLU LYS LEU VAL GLN LEU SEQRES 7 A 286 TYR ALA VAL VAL SER GLU GLU PRO ILE TYR ILE VAL MET SEQRES 8 A 286 GLU TYR MET SER LYS GLY SER LEU LEU ASP PHE LEU LYS SEQRES 9 A 286 GLY GLU THR GLY LYS TYR LEU ARG LEU PRO GLN LEU VAL SEQRES 10 A 286 ASP MET ALA ALA GLN ILE ALA SER GLY MET ALA TYR VAL SEQRES 11 A 286 GLU ARG MET ASN TYR VAL HIS ARG ASP LEU ARG ALA ALA SEQRES 12 A 286 ASN ILE LEU VAL GLY GLU ASN LEU VAL CYS LYS VAL ALA SEQRES 13 A 286 ASP PHE GLY LEU ALA ARG LEU ILE GLU ASP ASN GLU TYR SEQRES 14 A 286 THR ALA ARG GLN GLY ALA LYS PHE PRO ILE LYS TRP THR SEQRES 15 A 286 ALA PRO GLU ALA ALA LEU TYR GLY ARG PHE THR ILE LYS SEQRES 16 A 286 SER ASP VAL TRP SER PHE GLY ILE LEU LEU THR GLU LEU SEQRES 17 A 286 THR THR LYS GLY ARG VAL PRO TYR PRO GLY MET VAL ASN SEQRES 18 A 286 ARG GLU VAL LEU ASP GLN VAL GLU ARG GLY TYR ARG MET SEQRES 19 A 286 PRO CYS PRO PRO GLU CYS PRO GLU SER LEU HIS ASP LEU SEQRES 20 A 286 MET CYS GLN CYS TRP ARG LYS GLU PRO GLU GLU ARG PRO SEQRES 21 A 286 THR PHE GLU TYR LEU GLN ALA PHE LEU GLU ASP TYR PHE SEQRES 22 A 286 THR SER THR GLU PRO GLN TYR GLN PRO GLY GLU ASN LEU SEQRES 1 B 286 GLY HIS MET GLN THR GLN GLY LEU ALA LYS ASP ALA TRP SEQRES 2 B 286 GLU ILE PRO ARG GLU SER LEU ARG LEU GLU VAL LYS LEU SEQRES 3 B 286 GLY GLN GLY CYS PHE GLY GLU VAL TRP MET GLY THR TRP SEQRES 4 B 286 ASN GLY THR THR ARG VAL ALA ILE LYS THR LEU LYS PRO SEQRES 5 B 286 GLY THR MET SER PRO GLU ALA PHE LEU GLN GLU ALA GLN SEQRES 6 B 286 VAL LEU LYS LYS LEU ARG HIS GLU LYS LEU VAL GLN LEU SEQRES 7 B 286 TYR ALA VAL VAL SER GLU GLU PRO ILE TYR ILE VAL MET SEQRES 8 B 286 GLU TYR MET SER LYS GLY SER LEU LEU ASP PHE LEU LYS SEQRES 9 B 286 GLY GLU THR GLY LYS TYR LEU ARG LEU PRO GLN LEU VAL SEQRES 10 B 286 ASP MET ALA ALA GLN ILE ALA SER GLY MET ALA TYR VAL SEQRES 11 B 286 GLU ARG MET ASN TYR VAL HIS ARG ASP LEU ARG ALA ALA SEQRES 12 B 286 ASN ILE LEU VAL GLY GLU ASN LEU VAL CYS LYS VAL ALA SEQRES 13 B 286 ASP PHE GLY LEU ALA ARG LEU ILE GLU ASP ASN GLU TYR SEQRES 14 B 286 THR ALA ARG GLN GLY ALA LYS PHE PRO ILE LYS TRP THR SEQRES 15 B 286 ALA PRO GLU ALA ALA LEU TYR GLY ARG PHE THR ILE LYS SEQRES 16 B 286 SER ASP VAL TRP SER PHE GLY ILE LEU LEU THR GLU LEU SEQRES 17 B 286 THR THR LYS GLY ARG VAL PRO TYR PRO GLY MET VAL ASN SEQRES 18 B 286 ARG GLU VAL LEU ASP GLN VAL GLU ARG GLY TYR ARG MET SEQRES 19 B 286 PRO CYS PRO PRO GLU CYS PRO GLU SER LEU HIS ASP LEU SEQRES 20 B 286 MET CYS GLN CYS TRP ARG LYS GLU PRO GLU GLU ARG PRO SEQRES 21 B 286 THR PHE GLU TYR LEU GLN ALA PHE LEU GLU ASP TYR PHE SEQRES 22 B 286 THR SER THR GLU PRO GLN TYR GLN PRO GLY GLU ASN LEU HET DB8 A 601 36 HET DB8 B 601 36 HETNAM DB8 4-[(2,4-DICHLORO-5-METHOXYPHENYL)AMINO]-6-METHOXY-7-[3- HETNAM 2 DB8 (4-METHYLPIPERAZIN-1-YL)PROPOXY]QUINOLINE-3- HETNAM 3 DB8 CARBONITRILE HETSYN DB8 BOSUTINIB FORMUL 3 DB8 2(C26 H29 CL2 N5 O3) FORMUL 5 HOH *66(H2 O) HELIX 1 1 PRO A 263 GLU A 265 5 3 HELIX 2 2 SER A 303 LEU A 308 1 6 HELIX 3 3 GLN A 309 LEU A 317 1 9 HELIX 4 4 SER A 345 GLY A 352 1 8 HELIX 5 5 THR A 354 LEU A 358 5 5 HELIX 6 6 ARG A 359 MET A 380 1 22 HELIX 7 7 ARG A 388 ALA A 390 5 3 HELIX 8 8 GLU A 396 LEU A 398 5 3 HELIX 9 9 ALA A 430 GLY A 437 1 8 HELIX 10 10 THR A 440 LYS A 458 1 19 HELIX 11 11 VAL A 467 ARG A 477 1 11 HELIX 12 12 PRO A 488 TRP A 499 1 12 HELIX 13 13 GLU A 502 ARG A 506 5 5 HELIX 14 14 THR A 508 ASP A 518 1 11 HELIX 15 15 ASP A 518 THR A 523 1 6 HELIX 16 16 PRO B 263 GLU B 265 5 3 HELIX 17 17 LEU B 308 LYS B 315 1 8 HELIX 18 18 LEU B 346 GLY B 352 1 7 HELIX 19 19 THR B 354 LEU B 358 5 5 HELIX 20 20 ARG B 359 MET B 380 1 22 HELIX 21 21 ARG B 388 ALA B 390 5 3 HELIX 22 22 GLU B 396 LEU B 398 5 3 HELIX 23 23 ALA B 430 GLY B 437 1 8 HELIX 24 24 THR B 440 THR B 457 1 18 HELIX 25 25 VAL B 467 ARG B 477 1 11 HELIX 26 26 PRO B 488 TRP B 499 1 12 HELIX 27 27 GLU B 502 ARG B 506 5 5 HELIX 28 28 THR B 508 THR B 523 1 16 SHEET 1 A 5 LEU A 267 GLN A 275 0 SHEET 2 A 5 GLU A 280 TRP A 286 -1 O VAL A 281 N LEU A 273 SHEET 3 A 5 THR A 290 LEU A 297 -1 O THR A 290 N TRP A 286 SHEET 4 A 5 ILE A 334 GLU A 339 -1 O MET A 338 N ALA A 293 SHEET 5 A 5 LEU A 325 VAL A 328 -1 N TYR A 326 O VAL A 337 SHEET 1 B 2 TYR A 382 VAL A 383 0 SHEET 2 B 2 ARG A 409 LEU A 410 -1 O ARG A 409 N VAL A 383 SHEET 1 C 2 ILE A 392 VAL A 394 0 SHEET 2 C 2 CYS A 400 VAL A 402 -1 O LYS A 401 N LEU A 393 SHEET 1 D 5 LEU B 267 LYS B 272 0 SHEET 2 D 5 VAL B 281 TRP B 286 -1 O MET B 283 N VAL B 271 SHEET 3 D 5 THR B 290 THR B 296 -1 O ILE B 294 N TRP B 282 SHEET 4 D 5 TYR B 335 GLU B 339 -1 O MET B 338 N ALA B 293 SHEET 5 D 5 LEU B 325 VAL B 329 -1 N TYR B 326 O VAL B 337 SHEET 1 E 3 GLY B 344 SER B 345 0 SHEET 2 E 3 ILE B 392 VAL B 394 -1 O VAL B 394 N GLY B 344 SHEET 3 E 3 CYS B 400 VAL B 402 -1 O LYS B 401 N LEU B 393 SHEET 1 F 2 TYR B 382 VAL B 383 0 SHEET 2 F 2 ARG B 409 LEU B 410 -1 O ARG B 409 N VAL B 383 CISPEP 1 GLU A 332 PRO A 333 0 7.92 CISPEP 2 GLU B 332 PRO B 333 0 1.30 SITE 1 AC1 11 ALA A 293 LYS A 295 GLU A 310 VAL A 323 SITE 2 AC1 11 ILE A 336 MET A 338 GLU A 339 TYR A 340 SITE 3 AC1 11 MET A 341 SER A 342 LEU A 393 SITE 1 AC2 13 LEU B 273 ALA B 293 ILE B 294 LYS B 295 SITE 2 AC2 13 GLU B 310 VAL B 323 ILE B 336 MET B 338 SITE 3 AC2 13 GLU B 339 TYR B 340 MET B 341 GLY B 344 SITE 4 AC2 13 LEU B 393 CRYST1 41.869 63.047 73.956 79.03 87.82 89.91 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023884 -0.000040 -0.000918 0.00000 SCALE2 0.000000 0.015861 -0.003076 0.00000 SCALE3 0.000000 0.000000 0.013783 0.00000